To Be Discontinued Tablet Cardiovascular
Midodrine Hydrochloride Tabl · 501 days since initial FDA posting
FDA lists Midodrine Hydrochloride Tabl as To Be Discontinued (Upsher-Smith Laboratories, LLC).
No availability text on this FDA row.
Midodrine Hydrochloride Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Midodrine Hydrochloride Tablet
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Dosage Form
- Tablet
- Presentation
- Orvaten, Tablet, 5 mg (NDC 55154-5623-0)
- Package NDC
- 55154-5623-0
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Apr 28, 2025
- Last Updated
- Apr 28, 2025
- Therapeutic Category
- Cardiovascular
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Midodrine Shortage Records
Midodrine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Midodrine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Midodrine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Midodrine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Midodrine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet
Midodrine Hydrochloride Tablet
Upsher-Smith Laboratories, LLC
Tablet